Concept
Approval
10 Cancer Treatment Approvals From September 2026 and What They Mean for You | CURE / 2. Hyrnuo as a First Treatment for HER2-Mutant Lung Cancer
"Approved: Sept. 9 (accelerated approval) | Read more\n\nHyrnuo (sevabertinib), a pill, can now be used as the first treatment for advanced nonsquamous non-small cell lung cancer with certain HER2 mutations. In 69 previously untreated patients, tumors shrank in 75%. A larger trial is underway to confirm the benefit."
Related Ideas
- Hyrnuo Approval10 Cancer Treatment Approvals From September 2026 and What They Mean for You | CURE · References:
- Treatment Findings10 Cancer Treatment Approvals From September 2026 and What They Mean for You | CURE · Key Takeaways
- September Options10 Cancer Treatment Approvals From September 2026 and What They Mean for You | CURE · Key Takeaways
- Treatment Access10 Cancer Treatment Approvals From September 2026 and What They Mean for You | CURE · Key Takeaways
- Monitoring Update10 Cancer Treatment Approvals From September 2026 and What They Mean for You | CURE · 3. A Shorter Hospital Stay for Imdelltra
- Patient Access10 Cancer Treatment Approvals From September 2026 and What They Mean for You | CURE · 3. A Shorter Hospital Stay for Imdelltra
- Lyrfigtu Approval10 Cancer Treatment Approvals From September 2026 and What They Mean for You | CURE · 9. Lyrfigtu for FGFR2-Positive Bile Duct Cancer
- Etcamah Approval10 Cancer Treatment Approvals From September 2026 and What They Mean for You | CURE · 1. Etcamah for ESR1-Mutated Breast Cancer